Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Pyridoxine reduces cholesterol and low-density lipoprotein and increases antithrombin III activity in 80-year-old men with low plasma pyridoxal 5-phosphate

Författare

Summary, in English

We have previously observed that pyridoxine treatment reduced plasma total cholesterol (TC) and low-density lipoprotein (LDL) cholesterol concentrations and increased antithrombin III (AT III) activity in atherosclerotic patients with subnormal plasma pyridoxal 5-phosphate (PLP) levels. In order to confirm these results, we selected 17 males with low plasma PLP levels from a group of 122 80-year-old males in whom PLP has been determined. After supplementation with 120 mg of pyridoxine per day for 8 weeks their mean plasma TC and LDL cholesterol concentrations were decreased by 10% (p less than 0.01) and 17% (p less than 0.001), respectively. There was no effect on high-density lipoprotein cholesterol and triglycerides but plasma AT III activity was increased by 6% (p less than 0.05). The mechanism by which pyridoxine acts is unclear but it is hypothesized that pyridoxine-derived PLP may enhance the catabolism of LDL and the activity of AT III by inhibiting their glycosylation.

Publiceringsår

1990-12

Språk

Engelska

Sidor

873-877

Publikation/Tidskrift/Serie

Scandinavian Journal of Clinical & Laboratory Investigation

Volym

50

Issue

8

Dokumenttyp

Artikel i tidskrift

Förlag

Informa Healthcare

Ämne

  • Gerontology, specializing in Medical and Health Sciences
  • Pharmacology and Toxicology
  • Cardiac and Cardiovascular Systems
  • Neurology
  • Medicinal Chemistry

Nyckelord

  • cholesterol
  • pyridoxal 5-phosphate
  • antithrombin III
  • pyridoxine
  • low-density lipoproteins

Status

Published

Forskningsgrupp

  • Geriatric Medicine
  • Clinical Coagulation, Malmö
  • Rehabilitation medicine
  • Stroke policy and quality register research

ISBN/ISSN/Övrigt

  • ISSN: 1502-7686